论文部分内容阅读
目的:探讨溶栓治疗脑出血与脑微出血的相关性。方法:选择我院于2011年3月至2013年4月期间收治的接受溶栓治疗的38例脑出血患者作为观察组,另选择同期收治的未接受溶栓治疗的38例患者作为对照组,两组研究对象均行颅脑MRI检查,比较两组患者的脑微出血情况。结果:观察组脑微出血发生率显著高于对照组,差异p<0.05;观察组脑微出血病灶数显著高于对照组,差异p<0.05;观察组脑叶微出血百分比显著高于非脑叶微出血,差异p<0.05;对照组脑叶微出血百分比与非脑叶微出血比较,无显著差异p>0.05。结论:抗栓治疗脑出血后患者发生脑微出血风险增加,提示临床治疗中需合理应用溶栓治疗。
Objective: To investigate the correlation between thrombolytic therapy and cerebral hemorrhage. Methods: Thirty-eight patients with cerebral hemorrhage undergoing thrombolysis in our hospital from March 2011 to April 2013 were selected as the observation group. Thirty-eight patients who did not receive thrombolysis during the same period were selected as the control group, Two groups of subjects underwent brain MRI examination to compare the two groups of patients with cerebral micro-hemorrhage. Results: The incidence of cerebral hemorrhage in the observation group was significantly higher than that in the control group (p <0.05). The number of micro-hemorrhagic lesions in the observation group was significantly higher than that in the control group (p <0.05). The percentage of cerebral hemorrhage in the observation group was significantly higher than that in the control group Leaf micro-hemorrhage, the difference p <0.05; control group, the percentage of cerebral hemorrhage compared with non-cerebral hemorrhage, no significant difference p> 0.05. Conclusion: Antithrombotic therapy in patients with cerebral hemorrhage increased risk of cerebral micro-hemorrhage, suggesting that the clinical treatment of thrombolytic therapy should be reasonable use.